Oncology News

The addition of lenvatinib and pembrolizumab to chemotherapy did not extend OS for certain patients with advanced gastroesophageal adenocarcinoma, according to the agents’ manufacturers.

Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in the PI3K pathway, according to results of the randomized ALASCCA study presented at ASCO Gastrointestinal Cancers Symposium.

An investigational blood-based test identified nearly 80% of individuals who had colorectal cancer, according to results of a large prospective trial presented at ASCO Gastrointestinal Cancers Symposium.

Increased intake of calcium and dairy reduced the risk for colorectal cancer, a prospective cohort analysis published in Nature Communications revealed.

A French cohort study confirmed high risks for lymphoma and small bowel cancer in patients with celiac disease but also found elevated risks for pancreatic, esophageal, gastric and colonic cancers, as well as inflammatory digestive diseases.

Cost-effectiveness and optimal stopping ages for colorectal cancer screening after age 75 years appear to be associated with an individual’s age, sex, comorbidity status and screening history, according to results of an economic evaluation.

The FDA approved two oncology regimens on Jan. 16.

A new electronic health record-based model accurately predicted risk for gastric cancer using demographic, behavioral and clinical data and may be leveraged to increase screening in at-risk populations.

Improvement in adenoma detection rate among physicians with a baseline rate of less than 26% was significantly associated with decreased patient risk for colorectal cancer, according to results of an observational study conducted in Poland.